AI-Enhanced Heart Failure Screening Proves Cost-Effective in Long-Term Study

AI-ECG Tools Show Promise in Early Heart Failure Detection

A recent study published in Mayo Clinic Proceedings: Digital Health has revealed that artificial intelligence-enhanced electrocardiogram (AI-ECG) tools are not only effective in identifying unknown cases of weak heart pumps but are also cost-effective in the long term, particularly in outpatient settings 1

1

2

2

3

3

4

4

.

The Challenge of Detecting Heart Failure

Incremental drops in heart function can be challenging to detect, as patients may not always exhibit symptoms when their heart is not pumping effectively. Traditionally, doctors may not order diagnostic tests like echocardiograms unless symptoms are present. However, the AI-ECG tool has shown promise in catching hidden signals of heart failure during routine visits 1

1

2

2

.

Cost-Effectiveness of AI-ECG Screening

The study, which analyzed data from 22,000 participants in the EAGLE trial, found that the cost-effectiveness ratio of using AI-ECG was $27,858 per quality-adjusted life year (QALY) 1

1

2

2

3

3

4

4

. This measure takes into account both the quality of life and years lived. Notably, the program proved to be even more cost-effective in outpatient settings, with a significantly lower cost-effectiveness ratio of $1,651 per QALY 1

1

2

2

3

3

4

4

.

Methodology and Findings

Researchers simulated the long-term progression of heart disease using real-world information from the EAGLE trial. They categorized patients as either AI-ECG positive (requiring further testing for low ejection fraction) or AI-ECG negative (no further tests needed) 1

1

2

2

3

3

4

4

.

Dr. Xiaoxi Yao, a professor of Health Services Research at Mayo Clinic and senior author of the study, explained:

"We followed the normal path of care and looked at what that would cost. Did they have an echocardiogram? Did they stay healthy or develop heart failure later and need hospitalization? We considered different scenarios, costs and patient outcomes" 1

1

2

2

3

3

4

4

.

Implications for Patient Care

Dr. Peter Noseworthy, a Mayo Clinic cardiologist and co-author of the study, emphasized that using AI to detect hidden signals of heart failure during routine visits could lead to earlier treatment for patients. This early intervention has the potential to delay or stop disease progression and reduce related medical costs over time 1

1

2

2

3

3

4

4

.

Future Directions

The researchers stress the importance of cost-effectiveness in evaluating AI technologies for clinical practice implementation. Dr. Yao noted:

"We know that earlier diagnosis can lead to better and more cost-effective treatment options. To get there, we have been establishing a framework for AI evaluation and implementation. The next step is finding ways to streamline this process so we can reduce the time and resources required for such rigorous evaluation" 1

1

2

2

3

3

4

4

.

This study, funded by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, represents a significant step forward in the integration of AI technologies in healthcare, potentially improving patient outcomes while optimizing resource allocation.